Shandong Jincheng Pharmaceutical and Chemical Co Ltd Capital Reinvestment Ratio
Shandong Jincheng Pharmaceutical and Chemical Co Ltd capital reinvestment ratio. Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) has a Capital Reinvestment Ratio of 0.49x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥79.81 Million) in capital expenditures (CN¥38.83 Million). See 300233 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Shandong Jincheng Pharmaceutical and Chemical Co Ltd (2008–2025)
Capital reinvestment ratio of Shandong Jincheng Pharmaceutical and Chemical Co Ltd from 2008 to 2025. This chart tracks Shandong Jincheng Pharmaceutical and Chemical Co Ltd's Capital Reinvestment Ratio across 18 annual periods. See Shandong Jincheng Pharmaceutical and Che (300233) flexibility index to measure the company's free cash flow as a share of total liabilities.
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Capital Reinvestment Ratio by Year (2008–2025)
Shandong Jincheng Pharmaceutical and Chemical Co Ltd capital reinvestment ratio by year from 2008 to 2025. For the full cash flow conversion analysis, see Shandong Jincheng Pharmaceutical and Che cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.32x | CN¥319.64 Million | CN¥100.88 Million | ▼ -34.4% |
| 2024 | 0.48x | CN¥296.59 Million | CN¥142.61 Million | ▼ -6.9% |
| 2023 | 0.52x | CN¥664.08 Million | CN¥342.90 Million | ▼ -64.7% |
| 2022 | 1.46x | CN¥255.63 Million | CN¥373.67 Million | ▲ +69.9% |
| 2021 | 0.86x | CN¥437.19 Million | CN¥376.14 Million | ▲ +72.5% |
| 2020 | 0.50x | CN¥546.13 Million | CN¥272.44 Million | ▼ -20.3% |
| 2019 | 0.63x | CN¥577.98 Million | CN¥361.65 Million | ▼ -37.0% |
| 2018 | 0.99x | CN¥352.20 Million | CN¥349.88 Million | ▼ -22.2% |
| 2017 | 1.28x | CN¥151.83 Million | CN¥193.80 Million | ▲ +94.0% |
| 2016 | 0.66x | CN¥241.48 Million | CN¥158.89 Million | ▼ -14.4% |
| 2015 | 0.77x | CN¥207.92 Million | CN¥159.85 Million | ▲ +5.7% |
| 2014 | 0.73x | CN¥219.46 Million | CN¥159.57 Million | ▼ -57.4% |
| 2013 | 1.71x | CN¥93.92 Million | CN¥160.18 Million | ▲ +35.2% |
| 2012 | 1.26x | CN¥86.61 Million | CN¥109.21 Million | ▼ -41.4% |
| 2011 | 2.15x | CN¥62.69 Million | CN¥135.00 Million | ▲ +73.6% |
| 2010 | 1.24x | CN¥108.67 Million | CN¥134.78 Million | ▲ +41.5% |
| 2009 | 0.88x | CN¥105.62 Million | CN¥92.58 Million | ▼ -49.9% |
| 2008 | 1.75x | CN¥30.23 Million | CN¥52.87 Million | — |